What is the address of GRELAN - Medisch Laboratorium?

The registered office of GRELAN - Medisch Laboratorium is located at Heerbaan 28, 2970 Schilde.

Is GRELAN - Medisch Laboratorium still active?

Yes. According to the CBE (18 September 2026) GRELAN - Medisch Laboratorium is active, legal situation “Normale toestand”, started on 19 December 1991.

Is GRELAN - Medisch Laboratorium registered on Peppol?

No, GRELAN - Medisch Laboratorium is currently not registered on the Peppol network.

What is the enterprise number of GRELAN - Medisch Laboratorium?

The enterprise number of GRELAN - Medisch Laboratorium is BE0446122992.

When was GRELAN - Medisch Laboratorium founded?

GRELAN - Medisch Laboratorium was founded on 19 December 1991.

Who are the directors of GRELAN - Medisch Laboratorium?

According to the 2025 annual accounts, the directors of GRELAN - Medisch Laboratorium are: Greta Van der Jonckheyd.

Is GRELAN - Medisch Laboratorium a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 December 1991; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GRELAN - Medisch Laboratorium make in 2025?

GRELAN - Medisch Laboratorium posted a profit after taxes of € 522,633 in financial year 2025.

What is the revenue of GRELAN - Medisch Laboratorium?

As a small company, GRELAN - Medisch Laboratorium is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 650,967.

GRELAN - Medisch Laboratorium (Private Limited) - Schilde

Dossier GRELAN - Medisch Laboratorium, printed on 18 September 2026 from databakkes.be/en/0446122992/grelan-medisch-laboratorium. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

GRELAN - Medisch Laboratorium from Schilde, company number BE0446122992, closed financial year 2025 with a result of € 522,633 after tax. For that financial year GRELAN - Medisch Laboratorium recorded a gross margin of € 650,967 and equity of € 5.4 million. Compared with financial year 2024, the result moved from € 471,892 to € 522,633. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 8, 2025.

What it is worth Growing

€ 5.4 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 522,633

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.2 million

▲ 163% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 5.4 million.

People and assets in 2025

Vehicles and equipment

€ 85,304

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,220

▼ 81% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,677

▼ 55% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 823,962 Gross margin 2022: € 823,962 First fiscal year in the series	€ 529,755 Gross margin 2023: € 529,755 ▼ 36% vs 2022 (€ 823,962) Unfavourable step	€ 556,812 Gross margin 2024: € 556,812 ▲ 5% vs 2023 (€ 529,755) Favourable step	€ 650,967 Gross margin 2025: € 650,967 ▲ 17% vs 2024 (€ 556,812) Favourable step	▲ 17%
Profit after taxes	€ 416,542 Profit after taxes 2022: € 416,542 First fiscal year in the series	€ 447,273 Profit after taxes 2023: € 447,273 ▲ 7% vs 2022 (€ 416,542) Favourable step	€ 471,892 Profit after taxes 2024: € 471,892 ▲ 6% vs 2023 (€ 447,273) Favourable step	€ 522,633 Profit after taxes 2025: € 522,633 ▲ 11% vs 2024 (€ 471,892) Favourable step	▲ 11%
Equity	€ 4,392,950 Equity 2022: € 4,392,950 First fiscal year in the series	€ 4,600,223 Equity 2023: € 4,600,223 ▲ 5% vs 2022 (€ 4,392,950) Favourable step	€ 4,878,115 Equity 2024: € 4,878,115 ▲ 6% vs 2023 (€ 4,600,223) Favourable step	€ 5,400,748 Equity 2025: € 5,400,748 ▲ 11% vs 2024 (€ 4,878,115) Favourable step	▲ 11%
Total debts	€ 28,092 Total debts 2022: € 28,092 First fiscal year in the series	€ 100,648 Total debts 2023: € 100,648 ▲ 258% vs 2022 (€ 28,092) Unfavourable step	€ 275,234 Total debts 2024: € 275,234 ▲ 173% vs 2023 (€ 100,648) Unfavourable step	€ 196,521 Total debts 2025: € 196,521 ▼ 29% vs 2024 (€ 275,234) Favourable step	▼ 29%
Cash	€ 869,588 Cash 2022: € 869,588 First fiscal year in the series	€ 719,939 Cash 2023: € 719,939 ▼ 17% vs 2022 (€ 869,588) Unfavourable step	€ 448,753 Cash 2024: € 448,753 ▼ 38% vs 2023 (€ 719,939) Unfavourable step	€ 1,179,794 Cash 2025: € 1,179,794 ▲ 163% vs 2024 (€ 448,753) Favourable step	▲ 163%
Retained profit	€ 4,372,950 Retained profit 2022: € 4,372,950 First fiscal year in the series	€ 4,580,223 Retained profit 2023: € 4,580,223 ▲ 5% vs 2022 (€ 4,372,950) Favourable step	€ 4,858,115 Retained profit 2024: € 4,858,115 ▲ 6% vs 2023 (€ 4,580,223) Favourable step	€ 5,380,748 Retained profit 2025: € 5,380,748 ▲ 11% vs 2024 (€ 4,858,115) Favourable step	▲ 11%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 240,000 Dividend 2023: € 240,000 Unchanged (€ 0) Unchanged	€ 194,000 Dividend 2024: € 194,000 ▼ 19% vs 2023 (€ 240,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 194,000) Unchanged	▼ 100%
Balance sheet total	€ 4,421,042 Balance sheet total 2022: € 4,421,042 First fiscal year in the series	€ 4,700,871 Balance sheet total 2023: € 4,700,871 ▲ 6% vs 2022 (€ 4,421,042) Unchanged	€ 5,153,348 Balance sheet total 2024: € 5,153,348 ▲ 10% vs 2023 (€ 4,700,871) Unchanged	€ 5,597,269 Balance sheet total 2025: € 5,597,269 ▲ 9% vs 2024 (€ 5,153,348) Unchanged	▲ 9%

Key figures of GRELAN - Medisch Laboratorium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to GRELAN - Medisch Laboratorium?

What happened at GRELAN - Medisch Laboratorium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 8, 2025 New annual accounts for financial year 2025: profit of € 522,633 (▲ 11% vs 2024). Source: NBB ↗
2004 Greta Van der Jonckheyd became a director. NBB
Jan 27, 1992 New establishment in Schilde. KBO
Dec 19, 1991 Start of the company according to the CBE. KBO

In short

From € 416,542 profit in 2022 to € 522,633 profit in 2025.

Paid € 819,268 in corporate taxes since 2022.

Best year ever: 2025, with € 522,633 profit.

Paid out € 434,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at GRELAN - Medisch Laboratorium? We notify you, reason included.

Follow GRELAN - Medisch Laboratorium

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Greta Van der Jonckheyd

GRELAN - Medisch Laboratorium

Behind GRELAN - Medisch Laboratorium is Greta Van der Jonckheyd.

See the full network in the app

Directors

According to the 2025 annual accounts

Greta Van der Jonckheyd

Director

since 2004

Establishments

Establishment units

Physical locations of this company

Registered office

Heerbaan 28

2970 Schilde

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

HERTOGENPARK

€ 304,159 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0446.122.992
VAT number: BE 0446.122.992
Registered office: Heerbaan 28, 2970 Schilde
Names & denominations: GRELAN - Medisch Laboratorium · GRELAN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 December 1991
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗